Q2Earth
Chemicals & Related Products · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Palm Beach Florida, Atlanta, Georgia, Un...Phone Number
(561) 693-1423Website
www.q2earth.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Q2Earth
About Q2Earth: Q2Earth currently manages compost and soil manufacturing facilities, and holds a license for an all-natural soil health supplement called ABS. The Company is pursuing additional licensing opportunities in biotech and biosciences that will expand its intellectual property portfolio and create new business opportunities. data-reactid="17"About Q2Earth: Q2Earth currently manages compost and soil manufacturing facilities, and holds a license for an all-natural soil health supplement called ABS. The Company is pursuing additional licensing opportunities in biotech and biosciences that will expand its intellectual property portfolio and create new business opportunities.Explore more
Q2Earth Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Q2Earth your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Q2Earth launches new products
Congratulate Masked Content for being promoted to Masked Content at Q2Earth
Check if Q2Earth has recently received funding, and reach out quickly before it becomes old news!
Click to see if Q2Earth had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Q2Earth has new funding data
Earning: See what the market has to say on Q2Earth recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Q2Earth, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Q2Earth is spiking on competitors!
Recommended Actions
Find VP level buyers at Q2Earth
Find 3 more new buyers
Compare Similar Companies to Q2Earth
Compare insights from companies similar to Q2Earth, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Q2Earth is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Q2Earth is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Q2Earth.
Q2Earth Tech Stack
A closer look at the technologies used by Q2Earth
See more technologies
Q2Earth News & Media
Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer
Palm Beach, FL, April 28, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that its wholly-owned subsidiary, QSAM Therapeutics Inc. (“QSAM”), has signed a Patent and Technology License Agreement and Trademark Assignment with IGL Pharma, Inc. (“IGL”).Q2Earth Signs Exclusive Option Agreement to License Promising Drug to Treat Bone Cancer in Children
Palm Beach, FL, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that it has signed an Exclusive Dealing Option Agreement to provide the Company a 90-day period to negotiate with IGL Pharma Inc., and potentially execute a worldwide, exclusive license agreement for the radiopharmaceutical Samarium-153 DOTMP (“Sm-153 DOTMP”). Sm-153 DOTMP is a promising drug with initial indications for pediatric osteosarcoma, a devastating form of bone cancer aQ2Earth Appoints Douglas Baum, Senior Biosciences Executive, To Board of Directors
Palm Beach, FL, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that it has appointed Douglas R. Baum to its Board of Directors.Q2Earth Appoints Douglas Baum, Senior Biosciences Executive, To Board of Directors
Mr. Baum brings to the Company over 28 years of experience in the bioscience and biotech industries, including development, commercialization and marketing of multiple drugs and medical devices. Over his long senior executive tenure, including as CEO of Xeris Pharmaceuticals, he has overseen 15 product
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Q2Earth
Sign Up For FreeTo access detailed company insights
About Q2Earth: Q2Earth currently manages compost and soil manufacturing facilities, and holds a license for an all-natural soil health supplement called ABS. The Company is pursuing additional licensing opportunities in biotech and biosciences that will expand its intellectual property portfolio and create new business opportunities. data-reactid="... Read More
